Tag: Delta Care Rx News
Delta Care Rx named a Top 10 Pharmacy Management Solution Provider
FREMONT, Calif. /California Newswire/ -- Delta Care Rx, a leading pharmaceutical innovator in end of life care, has been named one of the "Top 10 Pharmacy Management Solution Providers of 2018," according to Healthcare Tech Outlook, a digital and print magazine publication of Valley Media, Inc.
Adapt by Delta Care Rx is new Patient-Clinician Palliative Care Tech Powered by TapCloud
PITTSBURGH, Pa., March 14, 2018 (SEND2PRESS NEWSWIRE) -- The simple touch of a finger sparks the newest innovation in the quest for quality, responsive patient-centered care. Adapt by Delta Care Rx, an advanced disease management and therapeutics solution, debuts a patient-clinician communication interface powered by TapCloud, a leading provider of real time patient generated health data.
Delta Care Rx Hospice Solutions Now Interface with HEALTHCAREfirst Electronic Health Records
PITTSBURGH, Pa., March 13, 2018 (SEND2PRESS NEWSWIRE) -- Delta Care Rx, a leading pharmaceutical innovator in end of life care, announces an exciting interface with HEALTHCAREfirst, a leading provider of web-based home health and hospice software, billing and coding services, Consumer Assessment of Healthcare Providers and Systems, or CAHPS, Surveys and advanced analytics.
Delta Care Rx Now Integrates with Electronic Medical Records from Suncoast by Complia Health
PITTSBURGH, Pa., Feb. 16, 2018 (SEND2PRESS NEWSWIRE) -- Delta Care Rx, a leading pharmaceutical innovator in end of life care, announces a robust integration with Suncoast by Complia Health, a leading global provider of home health care and hospice software solutions.
Patrick White, MD, of BJC Hospice, St. Louis is Inaugural Recipient of Delta Distinguished Scholar Award
PITTSBURGH, Pa., April 18, 2017 (SEND2PRESS NEWSWIRE) -- Delta Care Rx today announced the first-ever recipient of the Delta Distinguished Scholar award. Patrick White, MD, HMDC, FACP, FAAHPM, chief medical officer of BJC Hospice, St. Louis, and assistant professor of medicine at Washington University, has received an initial $25,000 research grant, with a $500,000 lifetime potential, for study into the comparative and cost effectiveness of pharmaceuticals.
